companydata.dkSidera Bio ApS: Financial statements 2025
CVR: 44381699
Sidera Bio ApS (CVR 44381699) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,287,281 and a net result of DKK -6,924,629. Equity amounted to DKK 85,864,083. The solvency ratio was 96.6%. The company had 4 employees in the financial year.
- Gross Profit
- -5,287,281 kr.
- Profit/Loss
- -6,924,629 kr.
- Equity
- 85,864,083 kr.
- Total Assets
- 88,858,903 kr.
- Employees
- 4
Find more companies like Sidera Bio ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of November 18, 2025, Søren Møller has joined the board of directors of Sidera Bio ApS.
As of November 18, 2025, Stefan Emanuel Luzi has joined the board of directors of Sidera Bio ApS.
As of November 18, 2025, Nandita Shangari has joined the board of directors of Sidera Bio ApS.
As of November 18, 2025, Tim Lohoff has joined the board of directors of Sidera Bio ApS.
As of November 18, 2025, Novo Holdings A/S is registered as an owner of Sidera Bio ApS with an ownership share of 15%.
As of November 18, 2025, is registered as an owner of Sidera Bio ApS with an ownership share of 15%.
As of November 18, 2025, is registered as an owner of Sidera Bio ApS with an ownership share of 25%.
As of November 18, 2025, is registered as an owner of Sidera Bio ApS with an ownership share of 5%.
As of November 18, 2025, is registered as an owner of Sidera Bio ApS with an ownership share of 10%.
Sidera Bio ApS has published its interim report for the period October 19, 2023 – December 31, 2024.
About Sidera Bio ApS
Sidera Bio ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GhostBio ApS. The management consists of Keld Flintholm Jørgensen. The company's owners include Novo Holdings A/S, RA Capital Healthcare Fund, L.P. and Forbion Ventures Fund VI Coöperatief U.A.. In 2025, the company reported a gross profit of DKK -5,287,281 and a net result of DKK -6,924,629. Equity amounted to DKK 85,864,083.